Zevra Therapeutics Inc (NASDAQ: ZVRA) stock closed at $11.78 on 10/15/25 after a major increase of 12.3%. Moreover, trading volume in this advance was exceptionally high at 232% of normal. The stock has risen 15.6% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Zevra Therapeutics has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Zevra Therapeutics has a slightly negative Appreciation Score of 34 but a good Power Rating of 73, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment